Purpose Patients with cancer are at increased risk of venous thromboembolism (VTE).
Laboratory tests measuring the overall thrombophilic tendency might be useful to assess …

Venous thromboembolism (VTE) occurs frequently in patients with cancer and contributes to
elevated morbidity and mortality. Risk factors for the occurrence of VTE events in patients …

The risk of venous thromboembolism (VTE) is increased in cancer patients. To improve
prediction of VTE in cancer patients, we performed a prospective and observational cohort …

There is a close interrelation between cancer and haemostasis, which is characterized by
changes in the haemostatic system, mostly an activation of coagulation in cancer patients …

Purpose Venous thromboembolism (VTE) is a well-recognized complication of cancer.
Laboratory parameters might be useful to assess the VTE risk in patients with cancer. The …

Venous thromboembolism (VTE) is an increasingly frequent complication of cancer and its
treatments. One in five cancer patients are estimated to develop venous and arterial events …

Cancer patients are at increased risk of deep vein thrombosis and pulmonary embolism. The
incidence among different groups of cancer patients varies considerably depending on …

Background: Cancer patients of the Department of Internal Medicine (Cancer Research) of
the Essen University Medical School (Tumor Clinics), Germany, were examined and …

Purpose Patients with cancer are at risk of venous thromboembolism (VTE). Tumor-related
factors could help estimate patients' individual risk for VTE. Currently, only scarce …

Background: In cancer patients, laboratory parameters that predict venous
thromboembolism (VTE) are scarce. Increased platelet count has been found to be a risk …